Research AI

Scans

Tools

Watchlists

Home

Charts

Watchlist

Products

Fermenta Biotech Ltd

FERMENTA

BSE

₹459.40-5.84%19 Oct 2026

Reports

Pharma API

Fermenta Biotech Ltd

FERMENTA

BSE

₹459.40

-5.84%

19 Oct 2026

SOICxStockScans Reports

Ask AI

Pharma API

Indices

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Price

Charts

Documents

Edit Ratios

Mkt Cap

Market Capitalization

₹1,354Cr

Close Price

₹460.15

Industry

Pharma API

Price To Earnings

22.32

Price To Sales

2.65

Revenue

₹511Cr

Rev Gr TTM

Revenue Growth TTM

-3.15%

PAT Gr TTM

PAT Growth TTM

-44.02%

Consolidated

Standalone

Numbers

Percentage

Quarter	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	57	99	97	78	95	156	140	136	130	137	122	122
Growth YoY Revenue Growth YoY%	-42.0	80.4	-7.4	-5.2	67.0	58.1	43.7	74.4	37.0	-12.2	-13.1	-10.6
Expenses ExpensesCr	71	74	92	77	76	103	103	108	104	112	102	104
Operating Profit Operating ProfitCr	-14	25	5	1	19	53	37	28	27	25	20	18
OPM OPM%	-24.5	25.4	5.5	1.0	19.8	34.0	26.4	20.7	20.5	18.2	16.4	14.8
Other Income Other IncomeCr	-6	3	5	3	3	2	4	9	5	1	14	4
Interest Expense Interest ExpenseCr	4	5	3	3	4	4	3	3	3	3	3	3
Depreciation DepreciationCr	6	6	6	6	6	6	6	6	5	5	5	5
PBT PBTCr	-29	16	1	-6	12	45	32	28	24	17	26	15
Tax TaxCr	0	6	8	0	1	7	-1	6	6	5	8	5
PAT PATCr	-29	10	-7	-6	11	38	33	22	18	12	19	10
Growth YoY PAT Growth YoY%	-243.6	126.5	-35.0	-368.3	138.3	279.3	566.7	464.3	62.1	-68.3	-44.2	-55.9
NPM NPM%	-51.1	10.1	-7.3	-7.6	11.7	24.2	23.8	15.8	13.8	8.8	15.3	7.8
EPS EPS₹	-7.3	3.4	-2.4	-2.0	3.9	12.7	11.8	7.5	6.2	4.4	6.7	3.4

Quarter	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	57	99	97	78	95	156	140	136	130	137	122	122
Growth YoY Revenue Growth YoY%	-42.0	80.4	-7.4	-5.2	67.0	58.1	43.7	74.4	37.0	-12.2	-13.1	-10.6
Expenses ExpensesCr	71	74	92	77	76	103	103	108	104	112	102	104
Operating Profit Operating ProfitCr	-14	25	5	1	19	53	37	28	27	25	20	18
OPM OPM%	-24.5	25.4	5.5	1.0	19.8	34.0	26.4	20.7	20.5	18.2	16.4	14.8
Other Income Other IncomeCr	-6	3	5	3	3	2	4	9	5	1	14	4
Interest Expense Interest ExpenseCr	4	5	3	3	4	4	3	3	3	3	3	3
Depreciation DepreciationCr	6	6	6	6	6	6	6	6	5	5	5	5
PBT PBTCr	-29	16	1	-6	12	45	32	28	24	17	26	15
Tax TaxCr	0	6	8	0	1	7	-1	6	6	5	8	5
PAT PATCr	-29	10	-7	-6	11	38	33	22	18	12	19	10
Growth YoY PAT Growth YoY%	-243.6	126.5	-35.0	-368.3	138.3	279.3	566.7	464.3	62.1	-68.3	-44.2	-55.9
NPM NPM%	-51.1	10.1	-7.3	-7.6	11.7	24.2	23.8	15.8	13.8	8.8	15.3	7.8
EPS EPS₹	-7.3	3.4	-2.4	-2.0	3.9	12.7	11.8	7.5	6.2	4.4	6.7	3.4

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	153	164	302	403	292	377	399	350	336	469	525	511
Growth Revenue Growth%	8.2	6.9	84.2	33.6	-27.7	29.3	5.6	-12.2	-4.1	39.9	11.9	-3.1
Expenses ExpensesCr	135	152	209	255	226	296	337	332	308	360	426	421
Operating Profit Operating ProfitCr	19	12	93	149	65	82	61	18	28	110	100	90
OPM OPM%	12.3	7.3	30.8	36.9	22.4	21.6	15.4	5.0	8.2	23.4	19.0	17.6
Other Income Other IncomeCr	3	3	9	12	12	8	8	-20	4	12	29	25
Interest Expense Interest ExpenseCr	6	10	14	21	19	18	17	21	17	14	12	11
Depreciation DepreciationCr	8	10	12	12	15	20	26	28	25	24	22	21
PBT PBTCr	7	-6	76	129	43	52	27	-51	-10	83	96	82
Tax TaxCr	4	3	21	11	-16	9	12	2	14	7	26	24
PAT PATCr	3	-8	55	118	60	43	15	-53	-24	76	70	58
Growth PAT Growth%	184.4	-403.4	766.3	115.0	-49.5	-28.5	-64.6	-452.8	54.8	418.2	-8.1	-44.0
NPM NPM%	1.8	-5.0	18.1	29.2	20.4	11.3	3.8	-15.2	-7.2	16.3	13.4	11.4
EPS EPS₹	-0.4	-4.2	3.1	13.6	20.6	15.8	5.3	-17.7	-5.4	26.4	24.7	20.6

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	153	164	302	403	292	377	399	350	336	469	525	511
Growth Revenue Growth%	8.2	6.9	84.2	33.6	-27.7	29.3	5.6	-12.2	-4.1	39.9	11.9	-3.1
Expenses ExpensesCr	135	152	209	255	226	296	337	332	308	360	426	421
Operating Profit Operating ProfitCr	19	12	93	149	65	82	61	18	28	110	100	90
OPM OPM%	12.3	7.3	30.8	36.9	22.4	21.6	15.4	5.0	8.2	23.4	19.0	17.6
Other Income Other IncomeCr	3	3	9	12	12	8	8	-20	4	12	29	25
Interest Expense Interest ExpenseCr	6	10	14	21	19	18	17	21	17	14	12	11
Depreciation DepreciationCr	8	10	12	12	15	20	26	28	25	24	22	21
PBT PBTCr	7	-6	76	129	43	52	27	-51	-10	83	96	82
Tax TaxCr	4	3	21	11	-16	9	12	2	14	7	26	24
PAT PATCr	3	-8	55	118	60	43	15	-53	-24	76	70	58
Growth PAT Growth%	184.4	-403.4	766.3	115.0	-49.5	-28.5	-64.6	-452.8	54.8	418.2	-8.1	-44.0
NPM NPM%	1.8	-5.0	18.1	29.2	20.4	11.3	3.8	-15.2	-7.2	16.3	13.4	11.4
EPS EPS₹	-0.4	-4.2	3.1	13.6	20.6	15.8	5.3	-17.7	-5.4	26.4	24.7	20.6

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	2	2	2	5	14	14	14	14	14	15	14
Reserves ReservesCr	128	142	124	246	295	346	358	301	274	348	392
Current Liabilities Current LiabilitiesCr	108	86	104	156	195	209	207	209	173	212	209
Non Current Liabilities Non Current LiabilitiesCr	24	49	146	145	110	117	128	115	89	44	39
Total Liabilities Total LiabilitiesCr	288	308	387	551	614	687	707	637	548	614	648
Current Assets Current AssetsCr	95	104	182	296	284	310	314	253	242	335	388
Non Current Assets Non Current AssetsCr	194	204	204	256	330	377	393	383	306	279	260
Total Assets Total AssetsCr	288	308	387	551	614	687	707	637	548	614	648

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	2	2	2	5	14	14	14	14	14	15	14
Reserves ReservesCr	128	142	124	246	295	346	358	301	274	348	392
Current Liabilities Current LiabilitiesCr	108	86	104	156	195	209	207	209	173	212	209
Non Current Liabilities Non Current LiabilitiesCr	24	49	146	145	110	117	128	115	89	44	39
Total Liabilities Total LiabilitiesCr	288	308	387	551	614	687	707	637	548	614	648
Current Assets Current AssetsCr	95	104	182	296	284	310	314	253	242	335	388
Non Current Assets Non Current AssetsCr	194	204	204	256	330	377	393	383	306	279	260
Total Assets Total AssetsCr	288	308	387	551	614	687	707	637	548	614	648

Consolidated

Standalone

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	7	2	59	90	34	63	43	116	105	41	93
Investing Cash Flow Investing Cash FlowCr	-15	7	-101	-97	-44	-42	-26	-55	-16	0	-43
Financing Cash Flow Financing Cash FlowCr	10	-12	89	12	-47	-1	-22	-41	-91	-51	-42
Net Cash Flow Net Cash FlowCr	1	-4	47	6	-57	20	-4	19	-1	-10	8
Free Cash Flow Free Cash FlowCr	-23	-17	42	55	-34	7	6	76	86	38	63
CFO To PAT CFO To PAT%	240.1	-23.2	108.1	76.6	57.9	147.2	288.4	-218.5	-438.8	53.5	132.1
CFO To EBITDA CFO To EBITDA%	34.6	16.0	63.7	60.7	52.8	76.7	70.7	659.5	382.9	37.3	93.0

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	7	2	59	90	34	63	43	116	105	41	93
Investing Cash Flow Investing Cash FlowCr	-15	7	-101	-97	-44	-42	-26	-55	-16	0	-43
Financing Cash Flow Financing Cash FlowCr	10	-12	89	12	-47	-1	-22	-41	-91	-51	-42
Net Cash Flow Net Cash FlowCr	1	-4	47	6	-57	20	-4	19	-1	-10	8
Free Cash Flow Free Cash FlowCr	-23	-17	42	55	-34	7	6	76	86	38	63
CFO To PAT CFO To PAT%	240.1	-23.2	108.1	76.6	57.9	147.2	288.4	-218.5	-438.8	53.5	132.1
CFO To EBITDA CFO To EBITDA%	34.6	16.0	63.7	60.7	52.8	76.7	70.7	659.5	382.9	37.3	93.0

Consolidated

Standalone

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr	160	176	654	755	626	737	605	315	446	805	939	1,354
Price To Earnings Price To Earnings			19.4	6.4	10.3	15.9	38.5			10.4	12.8	22.3
Price To Sales Price To Sales	1.0	1.1	2.2	1.9	2.1	1.9	1.5	0.9	1.3	1.7	1.8	2.6
Price To Book Price To Book	1.2	1.2	5.3	3.0	2.0	2.0	1.6	1.0	1.5	2.2	2.3	3.3
EV To EBITDA EV To EBITDA	10.8	21.0	8.5	5.8	12.3	11.3	13.2	27.0	19.1	7.7	10.1	16.8
Profitability Ratios Profitability Ratios
GPM GPM%	44.5	41.9	61.3	66.0	59.0	52.6	45.0	38.3	40.3	50.0	48.7	48.7
OPM OPM%	12.3	7.3	30.8	36.9	22.4	21.6	15.4	5.0	8.2	23.4	19.0	17.6
NPM NPM%	1.8	-5.0	18.1	29.2	20.4	11.3	3.8	-15.2	-7.2	16.3	13.4	11.4
ROCE ROCE%	7.4	2.0	30.7	33.5	12.1	11.7	7.2	-5.7	1.7	20.4	20.7	20.7
ROE ROE%	2.1	-5.7	43.4	47.1	19.2	11.8	4.0	-16.9	-8.3	21.1	17.3	17.3
ROA ROA%	0.9	-2.7	14.2	21.4	9.7	6.2	2.1	-8.3	-4.4	12.4	10.8	10.8
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr	160	176	654	755	626	737	605	315	446	805	939	1,354
Price To Earnings Price To Earnings			19.4	6.4	10.3	15.9	38.5			10.4	12.8	22.3
Price To Sales Price To Sales	1.0	1.1	2.2	1.9	2.1	1.9	1.5	0.9	1.3	1.7	1.8	2.6
Price To Book Price To Book	1.2	1.2	5.3	3.0	2.0	2.0	1.6	1.0	1.5	2.2	2.3	3.3
EV To EBITDA EV To EBITDA	10.8	21.0	8.5	5.8	12.3	11.3	13.2	27.0	19.1	7.7	10.1	16.8
Profitability Ratios Profitability Ratios
GPM GPM%	44.5	41.9	61.3	66.0	59.0	52.6	45.0	38.3	40.3	50.0	48.7	48.7
OPM OPM%	12.3	7.3	30.8	36.9	22.4	21.6	15.4	5.0	8.2	23.4	19.0	17.6
NPM NPM%	1.8	-5.0	18.1	29.2	20.4	11.3	3.8	-15.2	-7.2	16.3	13.4	11.4
ROCE ROCE%	7.4	2.0	30.7	33.5	12.1	11.7	7.2	-5.7	1.7	20.4	20.7	20.7
ROE ROE%	2.1	-5.7	43.4	47.1	19.2	11.8	4.0	-16.9	-8.3	21.1	17.3	17.3
ROA ROA%	0.9	-2.7	14.2	21.4	9.7	6.2	2.1	-8.3	-4.4	12.4	10.8	10.8
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

	AARTIDRUGS	SOLARA	AHCL	FERMENTA	ANUHPHR	VALIANTLAB	WANBURY
Market CapitalizationMkt CapCr	3,642	3,139	1,431	1,354	825	758	654
Close PriceClose₹	399.00	646.75	26.92	460.15	82.31	139.58	187.00
IndustryIndustry	Pharma API	Pharma API	Pharma API	Pharma API	Pharma API	Pharma API	Pharma API
Price To EarningsPE	19.06	84.43	44.87	22.32	18.66	47.32	10.82
Price To SalesPS	1.36	2.04	8.32	2.65	1.06	2.48	1.00
RevenueRevenueCr	2,678	1,535	172	511	779	306	653
Revenue Growth TTMRev Gr TTM%	10.5%	27.3%		-3.1%	9.7%	89.6%	3.6%
PAT Growth TTMPAT Gr TTM%	1.2%	476.3%		-44.0%	-4.3%	12,207.7%	30.0%

	AARTIDRUGS	SOLARA	AHCL	FERMENTA	ANUHPHR	VALIANTLAB	WANBURY
Market CapitalizationMkt CapCr	3,642	3,139	1,431	1,354	825	758	654
Close PriceClose₹	399.00	646.75	26.92	460.15	82.31	139.58	187.00
IndustryIndustry	Pharma API	Pharma API	Pharma API	Pharma API	Pharma API	Pharma API	Pharma API
Price To EarningsPE	19.06	84.43	44.87	22.32	18.66	47.32	10.82
Price To SalesPS	1.36	2.04	8.32	2.65	1.06	2.48	1.00
RevenueRevenueCr	2,678	1,535	172	511	779	306	653
Revenue Growth TTMRev Gr TTM%	10.5%	27.3%		-3.1%	9.7%	89.6%	3.6%
PAT Growth TTMPAT Gr TTM%	1.2%	476.3%		-44.0%	-4.3%	12,207.7%	30.0%